companies developing glp-1 drugs GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ It Is a Huge Market.
Description
286: E621E625 [DOI] [PubMed] [Google Scholar] 161.Gros R, You X, Baggio LL, et al
T., Zhou M., Qin Q., Bi X., Baudry M
Chris Serres: What the medications do is they produce this natural hormone, in the gut
Healthcare professionals should remain alert to emerging evidence in this rapidly evolving field whilst maintaining focus on proven therapeutic approaches
10.1056/NEJMoa1411892 34
